Insulin aspart, recombinant Subcutaneous and PhosLo Gelcap
Determining the interaction of Insulin aspart, recombinant Subcutaneous and PhosLo Gelcap and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: calcium acetate
Brand name: Calphron, Eliphos, PhosLo Gelcap, Phoslyra, PhosLo
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Phoslyra
- Insulin aspart, recombinant Subcutaneous-Phospha 250 Neutral
- Insulin aspart, recombinant Subcutaneous-Phosphasal
- Insulin aspart, recombinant Subcutaneous-Phospho-Soda Oral
- Insulin aspart, recombinant Subcutaneous-Phospholine Iodide
- Insulin aspart, recombinant Subcutaneous-Photofrin
- PhosLo Gelcap-Insulin degludec
- PhosLo Gelcap-Insulin Degludec (U-100) Prefilled Pens
- PhosLo Gelcap-Insulin Degludec (U-100) Vials
- PhosLo Gelcap-Insulin Degludec (U-200) Prefilled Pens
- PhosLo Gelcap-Insulin degludec and liraglutide
- PhosLo Gelcap-Insulin degludec and liraglutide Subcutaneous